MedTrace Logo

Qing'E Formula Therapy on Menopausal Symptoms

NCT01805765 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2019-04-05

No results posted yet for this study

Summary

The objective of this study is to evaluate whether a Chinese medicine formula (Qing'E) is effective in alleviating menopausal symptoms and safety.

Conditions

Interventions

DRUG

Qing'E pills

composed of eucommia, psoralen, walnuts and garlic

DRUG

Placebo

Containing 2% of Qing'E pills

Sponsors & Collaborators

  • Longhua Hospital

    collaborator OTHER

  • Shanghai Yueyang Integrated Medicine Hospital

    collaborator OTHER

  • Shanghai Municipal Hospital of Traditional Chinese Medicine

    collaborator OTHER

  • Shanghai Putuo District Center Hospital

    collaborator OTHER

  • Shanghai University of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Qingshan Zheng, Doctor · Shanghai Universitu of TCM

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01805765 on ClinicalTrials.gov